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THE MANAGEMENT OF ACUTE INFECTIVE CONJUNCTIVITIS IN GENERAL 
PRACTICE 
by Hazel Anne Everitt 
Acute infective conjunctivitis (AlC) is a common self-limiting condition presenting to general practice. 
However, evidence is limited on GPs current management of  AlC, patients' understanding of 
conjunctivitis or the most appropriate management strategy for AlC in general practice. 
The aims of  this thesis where to: 1) To determine GPs' current management strategies for AlC 2) To 
gain an understanding of  patients concerns and beliefs about AlC and develop a patient information 
leaflet (PIL). 3) To assess the effect of  common management strategies for AlC on symptom resolution 
and patients belief in antibiotics. 
Three complementary studies were used: 1) A postal survey of  300 GPs regarding their diagnosis and 
management of  AlC. 2) A qualitative study involving interviews with 25 patients to explore 
conjunctivitis from the patients' perspective. 3) An open randomised controlled tria~ with 307 recruits, 
to assess the effect of  different management strategies (immediate, delayed or no offer of  antibiotics; a 
patient information leaflet and an eye swab) for AlC in general practice. 
The results were: 1) Survey: 95% of  responding GPs usually prescribe topical antibiotics for AlC 
despite 58% stating that they thought at least half  of  the cases they see are viral in origin. Only 36% of 
GPs believed they could discriminate between viral and bacterial infection 2) Qualitative study: 
patients regarded conjunctivitis as a minor illness although some considered it might become more 
serious if  not treated. They stated a preference not to take medication but believed that conjunctivitis 
would not clear without treatment. However, they were open to alternative management approaches 
(e.g. delayed prescription approach) because they trusted their GPs judgement. Once aware of  the self-
limiting nature of  conjunctivitis, patients felt they would prefer to wait a few days to see if  it improved 
before seeking medical advice even if  this resulted in a few more days of  symptoms. 3) Randomised 
trial: different prescribing strategies did not affect symptom severity in the ftrst 3 days, but duration of 
moderately bad symptoms was less with antibiotics (control 4.83 days, immediate 3.26 days (p=O.OOl), 
delayed 3.86 days  (p=O.002)).  Compared with no initial offer of  antibiotics, antibiotic use was higher 
in the immediate group (control 30%, immediate 99% (p=0.001), delayed 53% (p=O.004)) as was 
belief  in the effectiveness of  antibiotics (control 47%, immediate 67% (p=0.03); delayed 55% 
(p=0.35)) and intention to re-consult (control 40%, immediate 68% (p=0.001), delayed 41 % (p=0.98)). 
A patient information leaflet or an eye swab had no affect on the main outcomes, but an eye swab 
seemed to increase patient worry about AlC and a PIL seemed to increase satisfaction with the 
consultation and the amount of  information received. Re-attendance in the next two weeks was less in 
the delayed group (delayed OR 0.33 (0.11;0.98); immediate OR 0.65 (0.26; 1.63)). 
In conclusion: Most general practitioners prescribe topical antibiotics for most cases of  acute infective 
conjunctivitis -a  self-limiting condition. Most patients are unaware of  the self-limiting nature of  AlC. 
A delayed prescribing approach is probably the most appropriate strategy to use for the management of 
acute conjunctivitis in primary care - it reduces antibiotic use by nearly 50%, shows no evidence of 
'medicalisation', provides similar symptom duration and severity to immediate prescribing and reduces 
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.  On 
average, a full-time general practitioner sees a patient with infective conjunctivitis every week. 
However, there is  little information available on how GPs currently manage this condition or 
on patients concerns and beliefs  and what they expect when they present to primary care. 
Evidence is  also  lacking on the most appropriate  management strategy for  acute infective 
conjunctivitis in general practice. 
This thesis presents a body of  work that was undertaken to help clarify these issues. 
1.1: Research Aims 
•  To determine GPs current management strategies for acute infective conjunctivitis. 
•  To  gain  an  understanding  of patients  concerns  and  beliefs  about  acute  infective 
conjunctivitis  and  develop  a  patient  information  leaflet  (PIL)  for  acute  infective 
conjunctivitis. 
•  To  assess  the  effect  of  common  management  strategies  for  acute  infective 
conjunctivitis on symptom resolution and patients belief  in antibiotics. 
1.2: Research methods 
Three complementary studies were used to address the research aims. The studies employed 
different research methodologies to address the different research aims. 
•  A postal survey of general practitioners regarding their current practice for diagnosis 
and management of  acute infective conjunctivitis. 
•  A  qualitative  study  involving  face  to  face  interviews  with  patients  to  explore 
conjunctivitis from the patients' perspective. Information from the interviews was used 
to aid the development of  a patient information leaflet and to inform the development 
of  the randomised controlled trial. 
•  An open  randomised  controlled trial  to  assess  the effect of different  management 
strategies for acute infective conjunctivitis in general practice.  Information from the 
GP survey and patient interviews were used to inform the development of  the trial. 
11 general practice based trial of fusidic acid versus placebo for acute infective conjunctivitis 
were resistant to fusidic acid. 
Topical antibiotics are unlikely to have any effect on viral conjunctivitis and there are no other 
recognised trea1Jnents  to shorten viral conjunctivitis
I5
;36.  Evidence is  lacking for the use of 
topical  antibiotics  in  viral  conjunctivitis  as  prophylaxis  against  superimposed  bacterial 
infection  15. 
The  difficulty distinguishing bacterial from  viral  conjunctivitis has  meant that most (over 
90%)  of patients  presenting  with  acute  infective  conjunctivitis  have  been  treated  with 
antibiotics empiricallyl-3. This means a significant number of  patients who present to general 
practice (50% or more) are likely to be given antibiotics  unnecessarily.  These patients are 
exposed to potential side effects of  antibiotics (eg allergic reactions (see 2.3.3.2: Side effects)) 
and the potential medicalising effect ofprescribing
37 (see 2.3.3.3: Medicalisation) without the 
potential benefits. 
Even in confirmed bacterial conjunctivitis there is some uncertainty regarding the role of 
antibiotics. The evidence for a beneficial effect from antibiotics is fairly weak, as few 
randomised controlled trials have been published comparing the effect of  antibiotics with 
placebo. At the time of  initiating this research, most of  the trials had taken place in the USA in 
secondary care, none in general practice
6
;38. The research evidence was summarised by a 
Cochrane systematic review
6 undertaken in April 1999 (published at the time of  the 
development of  this research). This revealed 3 published trials that fulfilled the criteria for 
inclusion in the review; Gigliotti et al 1984
27 with 66 subjects; Leibowitz 1991
39 with 177 
subjects and Miller et al 1992
40 with 284 subjects. They were all undertaken in selected 
specialist care populations and were heterogeneous in terms of  their inclusion and exclusion 
criteria, the nature of  the intervention and the outcome measures assessed (described below in 
the Table 2.3 .1.1). None of  the trials recorded an a priori sample size, described methods of 
randomisation or indicated if  researchers were blinded to trea1Jnent allocation
6
. 
Meta-analysis of  the three studies in the Cochrane review
6 indicated that acute bacterial 
conjunctivitis is frequently a self-limiting condition with clinical cure/significant improvement 
occurring by day 2 to 5 in 64% (99% CI 54 to 73) ofthose treated with placebo. Treatment 
with antibiotics was associated with significantly better rates of  clinical remission: Days 2 to 5 
RR 1.31 (99% CI 1.11 to 1.55 NNT =  5); Days 6 to 10 RRl.27, (99% CI 1.00 to 1.61, 
NNT=5). 
Thus, at the time of  initiating this research, there was some evidence that antibiotics improved 
clinical remission in the secondary care population but caution was required if  one attempted 
18 to extrapolate these finding to primary care as the case mix was likely to be different
6
. There 
was a clear need for further research on the effect of  antibiotics in a general practice 
population. 
19 In the last year, two new trials2s;41 and an update of  the Cochrane systematic review42 have 
been published regarding treatment for acute infective conjunctivitis in general practice. 
Rose et al41  published the results of  a randomised double blind placebo controlled trial of 
chloramphenicol treatment for acute infective conjunctivitis in children in primary care in the 
UK in the Lancet in July 2005. Rietveld et afs published a double blind placebo controlled 
trial of  fusidic acid for acute infectious conjunctivitis in adults in primary care in Holland in 
the British Journal of  General Practice in December 2005. The details of  these trials are 
summarised in table 2.3 .1.2 below. 
The Rose et at1 trial appears to be a rigorously conducted trial with a low drop out rate: only 
nine children were lost to follow up - one in the chloramphenicol group and 8 in the placebo 
group. It was undertaken in Oxfordshire, an area of  relatively less deprivation than the general 
population of  the UK, but there is no reason to believe that this should have a significant 
impact on the results. The level of  pathogen identification was higher (80%) than previous 
studies where levels of  36%26 and 50%21;22;33 have been found. The authors attribute this to the 
training given in the sampling technique and the diagnostic ability of  the referring physicians. 
The conclusion from the Rose et al trial41  was that most children presenting with acute 
infective conjunctivitis in primary care will get better by themselves and do not need treatment 
with an antibiotic. They suggest that the health economic argument against prescribing for 
acute infective conjunctivitis is compelling, as every year one million children present to UK 
general practitioners with conjunctivitis. However they highlight that parental concern and the 
current exclusion policy of  many schools and nurseries could make implementation of  change 
in prescription policy difficult. 
The Rietveld et afs trial had uneven randomisation groups, with 81  in fusidic acid and 100 in 
placebo group because of  an unrestricted randomisation procedure. This may have affected the 
study's precision. 18 patients were lost to follow up (8 in the fusidic acid and lOin the placebo 
group), thus analysis occurred on 163 patients. They had calculated a required sample size of 
88 patients per group and ended up with 73  in the fusidic acid group and 90 in the placebo 
group and thus were under-powered to detect the difference they set out to detect The baseline 
characteristics of  the randomisation groups were different for sex, age, history of 
conjunctivitis, foreign body sensation in the eye and bilateral involvement which is 
unfortunate in a randomised trial. This may be due to chance or to some problem with the 
randomisation procedure. However, the ability of  the study to assess a treatment effect may be 
compromised if  the two groups are different at baseline. This trial had a 32% (58/181) 
21 (ie consistently under or over-reporting an aspect of  behaviour) then the survey results would 
be biased - a fact that must be considered when interpreting the results of  surveys. Another 
potential source of  bias is expectation bias. This is when the person filling in the questionnaire 
gives responses that reflect what they think the researchers want to hear rather than actual 
behaviour (eg GPs may report what they believe is best practice rather than what they actually 
do). Ensuring that the respondents know that their responses are confidential may help to 
reduce this source of  bias. 
Another source of  bias in surveys is response bias. This occurs when not all respondents 
complete the survey and when those that respond differ systematically from those that do not 
respond. This can be reduced by achieving a high response rate. Potential response bias can be 
assessed by comparing the characteristics of  the responders to the non-responders. 
Care must also be taken when constructing questionnaires for surveys to ensure that they are 
collecting the correct information and that the questions are understandable and not open to 
differences in interpretation. This is achieved by paying attention to reliability and validity76 
(see below). 
Streiner and Norman76describe reliability as 'a fundamental way to reflect the amount of  error, 
both random and systematic, inherent in any measurement'. 
Reliability is a measure of  the ratio of  the variability between patients to the total variability 
(the sum of  the patient variability and measurement error). Thus zero indicates no reliability 
and one indicates no measurement error and perfect reliability76. 
Streiner and Normans defmition, that includes random error, means that reliability is specific 
to the population in which the test is performed. They see this as 'a realistic view of  the act of 
measurement and not a limitation on reliability'. However, others hold conflicting views, 
Bland and Altman
77 see the link of  the measure to the population in which the test is 
performed as a failure of  conventional methods in assessing reliability. They have proposed an 
alternative method for examining agreement between different methods of  clinical 
measurement which attempts to separate the bias of  the instrument from random error. 
Inter- and intra-observer reliability can both be assessed. However, inter-observer reliability 
was not relevant to this survey (since I was attempting to find out what GPs did, not whether 
they were right in doing so). However, intra-observer (test-retest) reliability (assessing 
whether responses change if  the questionnaire is re-administered to the same participant within 
a short time frame) was a potentially important issue and was assessed (see 3.2.5: Test/retest 
reliability). Internal reliability was not assessed for this study. It  was less important to assess 
the correlation of  items on the questionnaire with each other, than to try and achieve a high 
31 4.4: Rigor in qualitative research 
All research should be conducted in a rigorous manner so that the results are reliable, valid 
and transferable.  Qualitative research has often been criticised for lacking scientific rigor88. 
Mays and Pope
88 described the most common criticisms as being that it is merely an assembly 
of anecdote and personal  impressions,  strongly subject to researcher bias  and that it  lacks 
reproducibility  and generalis  ability.  However they  also  described how systematic  and  self 
conscious research design, data collection, intetpretation and communication can be used to 
ensure rigor
88
;89. They suggested a range of  questions to ask of  a qualitative study to critically 
scrutinise its rigor: 
1) Overall, did the researcher make explicit in the account the theoretical framework and 
methods used at every stage of  the research? 
2) Was the context clearly described? 
3) Was the sampling strategy clearly described and justified? 
4) Was the sampling strategy theoretically comprehensive to ensure the generalisability of  the 
conceptual analyses (diverse range of  individuals and settings, for example)? 
5) How was the fieldwork undertaken? Was it described in detail? 
6) Could the evidence (fieldwork notes, inter-view transcripts, recordings, documentary 
analysis, etc) be inspected independently by others; if  relevant, could the process of 
transcription be independently inspected? 
7) Were the procedures for data analysis clearly described and theoretically justified? Did they 
relate to the original research questions? How were themes and concepts identified from the 
data? 
8) Was the analysis repeated by more than one researcher to ensure reliability? 
9) Did the investigator make use of  quantitative evidence to test qualitative conclusions where 
appropriate? 
10) Did the investigator give evidence of  seeking out observations that might have 
contradicted or modified the analysis? 
11) Was sufficient of  the original evidence presented systematically in the written account to 
satisfy the sceptical reader of  the relation between the interpretation and the evidence (for 
example, were quotations numbered and sources given)? 
I undertook reading and training into qualitative research techniques, was closely supervised 
by  a  qualitative  supervisor with  whom I  was  able to  discuss  points  of methodology  and 
44 England and a rank of 32,482 the least deprived). The most deprived area in this study had a 
rank of 13,858 out of the 32,482 areas in England. Thus this study had no participants from 
areas of  very high deprivation. 
4.8.2: Table 5: Characteristics of participants 
Characteristics of  participants (n=25) 
Adult patients 





Recruited by GP  12 
Recruited by Practice Nurse  13 
male (3), female (10) 
male (0), female (11) 
female 
Age Range  13 to 90 years 
Index of  multiple deprivation score  range 1.54 to 20.01, median 7.92, IQR 1.91 to 17.92 
(from postcode area of  participant ) 
4.8.3: Themes 
Six themes were developed; 
1) Perceptions of  acute infective conjunctivitis, 
2) Perceptions of  medicines, 
3) The consultation for conjunctivitis, 
4) Responses to different management strategies for conjunctivitis, 
5) Information wants and needs, 
6) Different responses to conjunctivitis for oneself and for ones' child. 
Each theme comprises a number of  categories or subthemes. These themes are presented 
below supported by extracts from interview data and with a discussion of  the underlying 
concepts. 
50 Chapter 5: Randomised controlled trial of management strategies for acute infective 
conjunctivitis in general practice 
5.1: Introduction 
The  literature  review  revealed  a  lack of evidence  for  the  current  management  of acute 
infective  conjunctivitis  (see  Chapter  2).  I  undertook  this  trial  to  help  clarify  the  most 
appropriate  way  to  mange  acute  infective  conjunctivitis  in  general  practice.  Information 
collected from the GP survey (Chapter 3) and the Qualitative Study (Chapter 4) was used to 
inform the development of  the trial. 
5.2: Ethical Considerations and the Research Governance 
Full  ethical  approval  for  the  trial  was  obtained  from  the  relevant  ethical  committees, 
Southampton and SW Hampshire LREC no. 267/99, Portsmouth and SE Hampshire LREC no. 
09199/894, Salisbury LREC no. SA 27/99 and Dorset LREC no. 46103/S. 
As discussed in the Ethical considerations section for the qualitative study, I adhered to the 
principals  of the  'The Research  Governance  Framework  for  Health  and  Social  Care,102 
published in 2001 when conducting the trial. 
I used the principles from the MRCs Guidelines for Good Clinical Practice in Clinical Trials 
1998
103 for the management of  the trial. I did not initially have a Trial Steering Committee to 
oversee the trial but instituted one in 2003 just over half way through the trial to ensure the 
trial complied with the principals of  Good Research Governance. 
The Trial was registered with the International Standard Randomised Controlled Trial Register 
by the MRC in Jan 2003. Trial Registration no: ISRCTN32956955. 
As PCTs (Primary Care Trusts) developed Research Governance roles I contacted the PCTs of 
GPs and Practice Nurses who were recruiting patients for the trial and provided them with 
information on the trial.  As required by the PCTs, I obtained an Honorary Research Contract 
with one of  the participating PCTs (New Forest PCT). 
When the ED Directive on Clinical Trails was published and then brought into force in May 
2004 I followed MRC guidelines on implementing the directive
104
•  I contacted the Medicines 
and Healthcare products Regulatory Agency (MHRA)105 and obtained the required paperwork 
for  using  chloramphenicol  eye  drops  in  a  trial  setting.  I  also  arranged  for  the  School  of 
Medicine to act as Sponsor for the trial. 
I applied for Adhoc funding from the Department of Heaith to be able to reimburse GPs for 
the extra time taken to recruit patients to the trial. This was granted for £3,300 in total (ie £10 
66 per patient recruited). Nonnallya consultation regarding conjunctivitis takes a very short time 
(often less than 5 minutes) and GPs sometimes see it as a 'catch up' appointment where they 
can make up time if  they are running late. However recruiting a patient takes 10 to 15 minutes 
and so it impacts on their surgery time. The GPs were sent a cheque quarterly, £10 for each 
patient recruited.  Some put the money into practice funds,  some kept it for themselves and 
others gave it to charity. I do not believe that the £10 per a patient was a great incentive to GPs 
to participate in the trial but feel it at least acknowledged that they were undertaking additional 
work load to help with the trial. 
5.3 Rationale for a factorial open randomised controlled trial 
Although observational studies can give estimates of  treatment that are similar to randomised 
trials, the randomised controlled trial is the most powerful way to assess differences between 
treatments  since it can control for  confounding - both known and unknown  106; 107.  Double 
blind  trials  give  the  best evidence  for  efficacy by controlling  the placebo  effect  but the 
behaviour and  perceptions of patients  and  doctors  may  not be generalisable  to  a  normal 
clinical setting. Open trials more closely approximate everyday practice and thus can provide 
important  evidence  of effectiveness.  They  are  essential  when  outcome  measures  include 
patients'  perceptions and  choices  in  response  to  different  strategies,  for  example, whether 
"delayed" prescriptions are collected, the perceived efficacy of  antibiotics, or the likelihood of 
future attendance when symptoms have resolved without treatment
44
.  The main disadvantage 
of  using an open approach is the possibility of bias due to the placebo effect. However it has 
been shown in previous trials
44
;45 that the use of  structured advice packages enable the general 
practitioner to support each proposed strategy and function as the placebo in each group (see 
Method  for  further  infonnation  on  the  advice  packages).  This  type  of open  randomised 
controlled trial  design has been used successfully to  research antibiotic prescribing in  sore 
throat, otitis media and cough within this research departrnent44-46. 
A factorial design107;108 was chosen for the trial because it has the major advantage of  enabling 
a number of  possible management strategies to be assessed at the same time, ie issues relevant 
to  medicalisation  and  self  management  (antibiotic  strategies,  patient  infonnation, 
microbiological  testing).  Montgomery  et al  in their paper108  on the  design,  analysis  and 
presentation of factorial  trials  describe  the advantages of factorial trials  over the standard 
parallel-groups design: '(factorial trials) enable efficient simultaneous investigation of  two (or 
more)  investigations by including all participants in the analyses'.  Thus the sample size is 
smaller than would otherwise be required.  The main disadvantage of a factorial trial is that 
67 unless  it is  specifically  powered to  assess  interactions  between the  strategies  (which  can 
involve  a  prohibitively  high  sample  size),  moderate  interactions  can  be  missed.  The 
investigation of  the interactions is a secondary analysis and may have poor precision
108
.  Thus, 
the possibility of undetected interactions must be considered when drawing conclusions from 
the trial. 
5.4: Trial Design 
A  3x2x2  factorial  design  was  chosen  to  enable  assessment  of the  effect  of antibiotic 
prescription, a patient information leaflet and of  performing eye swabs. 
See  the  literature  review  - 2.5:  Potential  management  strategies  for  acute  infective 
conjunctivitis - for more information on the current research evidence behind the potential 
strategies. 
The patients were randomised to receiving one of  3 treatments: 
1)  Immediate topical antibiotic eye drops (Chloramphenicol eye drops). 
2)  No antibiotic prescription. 
3)  A delayed prescription of antibiotic eye drops  (to  be collected from  the 
surgery at the parents' or patients' discretion after three days). 
As discussed in the literature review (and confirmed by the GP survey19) the most commonly 
used  management  strategy  for  acute  infective  conjunctivitis  in  general  practice  is  a 
prescription for immediate topical antibiotics  (topical chloramphenicol eye  drops  are most 
often prescribed in the UK). Thus any trial must compare other potential management options 
to  this.  An alternative option for managing a minor self-limiting illness  is  no prescription. 
Probably only half of  the cases of  acute infective conjunctivitis that present to general practice 
are bacterial in origin14  and thus have the potential to respond to antibiotics.  The Cochrane 
review
6  for  acute bacterial  conjunctivitis  revealed  that  64% of cases  of confirmed  acute 
bacterial conjunctivitis resolve by day 2-5  without treatment. Thus I decided to include a no 
prescription group was in the trial. 
The delayed prescription approach has been shown to be successful and acceptable to patients 
for other minor self-limiting illnesses
44;45  and patients interviewed in the qualitative study l09 
supported this as a possible management option. It has the potential to reduce the unnecessary 
use of  antibiotics and reduce medicalisation of  self-limiting illnesses
37
. Thus it was included in 
the trial.  A  decision was  required  as  to  how long the delay should be before the patient 
collected the prescription. Three days was chosen because, according to the literature
6
,  there 
68 was a reasonable likelihood that some cases of  conjunctivitis may have settled by that time but 
it was not too long a time to ask the patients to wait for treatment if  they still had symptoms. 
The patients were also randomised to receive a patient information leaflet (developed in the 
qualitative part of this study - see 'Development of the patient information leaflet' Section 
4.6, Appendix 4) or not to receive a leaflet. The leaflet was handed to the patient in the GP 
consultation for them to  read  and take  home.  Leaflets  can provide patients  with  relevant 
information and have been shown to be able to  change consulting behaviour in some studies 
(see the Literature review 2.5.3 for discussion of  the use of  patient information leaflets). 
The final component of  the factorial design was randomisation to have an eye swab sent for 
culture,  or  not  to  have  an  eye  swab.  Those  that  had  swabs  taken  would  provide 
microbiological  information  about  the  cohort.  Determination  of the  proportion  of acute 
infective conjunctivitis cases that have a bacterial aetiology in the general practice setting 
would enable an assessment of the proportion of patients that could potentially benefit from 
antibiotic prescription.  Viral  culture  is technically  more  difficult and more expensive than 
bacterial culture and thus was not within the scope of  this study. 
The reason for performing the swabs in only half  the participants was to assess whether taking 
a swab had an effect on participants' beliefs  in the need to seek medical advice for  future 
episodes of conjunctivitis.  It may be that performing a test (eye swab) has  a medicalising 
effect on participants and encourages them to feel they need to attend for medical advice. 
Summary of  the randomisation: 
Thus, in total there were 12 groups that the participants were randomised to: 












Delayed topical antibiotics, no eye swab, no patient information leaflet 
No antibiotics, no eye swab, no patient information leaflet 
Immediate topical antibiotics, eye swab, no patient information sheet 
Delayed topical antibiotics, eye swab, no patient information sheet 
No topical antibiotics, eye swab, no patient information sheet 
Immediate antibiotics, eye swab, patient information sheet 
Delayed topical antibiotics, eye swab, patient information sheet 
No topical antibiotics, eye swab, patient information sheet 
Immediate topical antibiotics, no eye swab, patient information sheet 
Delayed topical antibiotics, no eye swab, patient information sheet 
No topical antibiotics, no eye swab, patient information sheet 
69 Also see the trial consort diagram (Figure 3) 
5.5: Outcome measures 
The proposed outcome measures were duration and severity of  symptoms, satisfaction and 
compliance with the treatment, use of  antibiotics, perceived efficacy of  antibiotics and 
perceived importance of  seeing the doctor. 
After discussions with the Trial Steering Committee, 3 main outcome measures were agreed 
on: Duration of  moderate symptoms, severity score for the first 3 days of  symptoms and belief 
in the efficacy of  antibiotics for acute infective conjunctivitis (see below 5.6: Sample size 
calculation for further information). 
5.6: Sample size calculation 
The initial sample size calculation estimated that 204 patients would be required to detect a 
one day difference in symptom resolution and a 25% difference in belief  in antibiotics
44 for 
80% power and 5% level of  significance. This was based on the estimate that symptoms would 
settle on average by 5 to 6 days (Standard Deviation (SD) 3) and assumed a one day difference 
between resolution between the groups (No Antibiotics = 6 days, Delayed prescription = 5 
days, Immediate Antibiotics = 4 days). These figures were based on data from previous trials
6
. 
The sample size allowed for a 20% loss to follow-up based on previous studies
44
.  It  also 
assumed no interactions between prescribing strategies, receiving a leaflet and the effect of 
performing an eye swab. Calculation was by nomogram for multiple groups in a factorial 
trial
llO for the symptom resolution (see Figure 1 below) and Spida 1.6 version computer 
package for the belief  in antibiotics. 
As there was limited previous research data on which to base the estimates it was felt prudent 
to undertake an interim sample size calculation part way through the trial. 
A target for recruitment of300 patients was determined to allow for some leeway in the 
assumptions and to possibly enable assessment of  potential subgroups from secondary analysis 
(e.g. based on severity of  symptoms on day 1). 
70 patients for each treatment group or 240 in total for 80% power and 5% significance 
(including the 20% loss to follow up). 
Discussion with the Trial Steering Committee regarding the best principal outcomes for the 
study resulted in further calculations of  sample sizes for the duration of  moderate symptoms 
and severity of  symptoms in the first three days. 
The discussions resulted in the adoption of3 principle outcomes all at a significance level of 
1  % which resulted in the following sample size calculations: 
1) Duration moderate symptoms (a day between each group) - sample size 234. 
The mean number of  days of  moderate symptoms after seeing the Dr /Nurse was 3.75 days 
(SD 3.06) This very skewed data required transformation to enable a sample size calculation. 
Some values were zero so log transforming was not appropriate, but the square root 
transformation of  this variable was suitable: mean 1.76 (SD 0.81). Transforming back from 
square roots gave information on the difference in days to moderate symptom resolution that 
could be detected. To detect a difference of 1 day of  moderate symptoms required detection of 
square root means ofl.45, 1.76 and 2.02 (squared means = 2.10,3.09,4.08 i.e. roughly a day 
between each), this required 150 in total for a 5% level of  significance and 234 for 1  % 
significance. 
2) Severity of  symptoms (0.33 between each group) - sample size 264. 
Patients have the worst symptoms in the few days after seeing the doctor. Taking the mean of 
days 1 to 3 for each symptom, factor analysis suggested that 5 symptoms loaded strongly onto 
one factor, with power 80% and a mean item score of2.3 (i.e. on average at least one 
symptom rated a moderate problem), SD 1.03. 
An effect size of  0.66 is equivalent to more than half  items being rated a slight rather than a 
moderate problem (a similar effect size was agreed by the Trial Steering Committee of  the 
MRC cough trial). To detect a difference of  0.66 (the delayed prescription group 0.33 lower 
and the immediate antibiotic group 0.66 lower than the no Antibiotic group) requires 48 per 
group or 180 in total, for a significance level of  1  % 264 are needed. 
3) Beliefs in antibiotics (15% difference between each group) - sample size 246. 
Assuming beliefs in the importance of  antibiotics correspond to previous studies
37
;44 (85% 
Immediate antibiotic group, 70% Delayed antibiotic group, 55% No Antibiotic group) then 36 
per group are required or 138 in total for a 5% level significance.  For 1  % significance 198 are 
72 received at the management office (ie time of  the information in the post), that acute infective 
conjunctivitis  is  a  rapidly  resolving  condition  and  so  the  participants'  symptoms  had 
frequently resolved by the time I  managed to  contact them and difficultly getting hold of 
patients (as they did not take time offwork for this condition). 
Patients were given the envelope containing the questionnaire about eye infections and the 
diary at the end of  the consultation and asked to open it when they got home and to start filling 
it in that day. The diary was completed daily to avoid recall bias in the recording of  symptom 
severity. A self-completed questionnaire has advantages over repeated review appointments to 
gather information on symptom resolution because it reduces the amount of  clinician time, 
administration time, cost and inconvenience to the patient that is required for data collection. It 
also minimises the bias that could result from a researcher administered questionnaire. 
The signs and symptoms of  acute infective conjunctivitis are visible and relatively 
straightforward for a non medical person to assess. The end point of  ' no symptoms' should be 
relatively clear, so the duration of  the illness should be able to be documented quite accurately 
by patients themselves. However, it can be argued that patient scoring of  symptoms may not 
be as objective and reliable as that undertaken by a clinician. A self-completed questionnaire 
relies on the patients' perception of  the severity of  their illness.  Each individuals' assessment 
of  their symptoms may vary and may be influenced by external factors (such as their 
confidence with the treatment they receive and family and social pressures). Thus self-
completed questionnaire reflects the impact of  the symptoms on the patient in the wider 
context of  the patients' life and the management strategies used to treat the illness. 
Nevertheless, this is arguably the most valid measurement tool for a minor self-limiting illness 
where it is the patients' perceptions of  the illness that determines presentation for medical 
care, and thus patients' perceptions that should determine illness severity and resolution. 
The diary was filled in each day until patients were both free of  symptoms and had fmished 
their medication up to a maximum of2 weeks. In the case of  children under 12 years the 
parent was asked to help complete the diary (as used successfully in previous studied 
I 
undertaken by this group44). Parental recording of  child symptoms has been shown to be valid 
in previous trials  45 . 
Patients  also  answered  written  questions  on  SIX  point  Likert  scales  (extremely,  very, 
moderately, slightly, not very, not at all) at the beginning of  treatment, and at the end of the 
diary. The initial questions were about worries, satisfaction, and "legitimation" (attending the 
doctor to explain the illness to others) as used in previous studies44;45.  Those at the end of  the 
79 was shorter in the immediate and delayed antibiotic groups than the no antibiotic group (Table 
7). 
A significant interaction was found between immediate antibiotic prescription and having an 
eye swab performed (p=0.014) suggesting a longer duration of  illness for patients receiving 
both immediate antibiotics and an eye swab. 
A clustering effect by GP was found to be present for the duration of  mild symptoms 
(sigma=O.19 SE 0.0595% CI 0.11; 0.32, p=O.OOl). As for the duration of  moderate symptoms, 
if  p values and confidence intervals are calculated with the use of  robust standard errors (SE), 
it makes a small difference to the confidence intervals and no difference to the interpretation 
of  the results. RR for immediate compared to no antibiotic group (using robust SE) = 0.71, 
95% CI 0.58 to 0.S6, p=O.OOl  and for delayed compared to no antibiotic group RR = O.Sl, 
95% CI 0.68 to 0.94, p=O.OOS. 
Figure 5 shows cumulative graph of  resolution of  mild symptoms. Similar to the duration of 
moderate symptoms the curves converge, in this case after day 10. There is no significant 
difference between the immediate and no antibiotic groups by day 13 and a borderline 
significant difference between the delayed and no antibiotic groups at day 13 (OR for cure by 
day 13 of  mild symptoms for immediate antibiotic group compared to no antibiotic group = 
2.50,95% CI 0.61 to 10.2S, p=O.203, for delayed compared to no antibiotic group = 4.91,95% 
CI 0.97 to 24.83, p=0.05). 
88 5.10.7.6: Table 8: Main outcomes by patient information leaflet group for responders 
(adjusted for antibiotic group and eye swab) 
No Patient  Patient  Difference 
Information  Information  (Leaflet 
Leaflet  Leaflet group  from no 
Group  leaflet) 




Mean (sd)  1.93 (0.96)  2.02 (0.96) 
Difference  0.07 





Mean (sd)  3.88(2.87)  4.05(3.03) 
(days) 
Rate ratio  1.01 




Mean (sd)  5.62(3.19)  5.71(3.54) 
(days) 
Rate ratio  0.99 
95%CI  (0.89; 1.11) 
p=0.895 
Belief  in 
antibiotics 
Extremely or  51/88  55/96 
very effective  (58.0%)  (57.3%) 
Odds Ratio  1.02 






Extremely or  57/107  52/114 
very likely to  (53.3%)  (45.6%) 
reattend 
Odds Ratio  0.77 
95%CI  (0.44;1.33) 
p=O.346 
91 5.10.7.7: Table 9: Main outcomes by eye swab group for responders 
(adjusted for antibiotic group and patient infonnation leaflet) 
No  Eye swab  Difference (Eye 
Eye swab  Group  swab from no 
Group  eye swab) 
n=117  n=127 
Average 
symptom score 
(d ays  1-3) 
Mean (sd)  1.89 (0.90)  2.05 (0.98) 
Difference  0.17 





Mean (sd)  3.76(2.89)  4.15(3.00) 
(days) 
Rate ratio  1.10 





(days)  5.52(3.26)  5.81(3.48) 
Rate ratio  1.06 
95%CI  (0.95;1.18) 
p=0.291 
Belief  in 
antibiotics 
Extremely or  56/95  50/89 
very effective  (59.0%)  (56.2%) 
Odds Ratio  0.86 






Extremely or  53/109  56/112 
very likely to  (48.6%)  (50.0%) 
reattend 
Odds Ratio  1.10 
95%CI  (0.64;1.91) 
p=O.729 
92 with delayed antibiotics is likely to be half  a day reduction of  moderate symptoms.  It may 
well depend on the individual patients' circumstances (ie ability of  children to attend day 
care). 
Immediate prescribing of  antibiotics seems to 'medicalise' patients with acute infective 
conjunctivitis - as seen in research on other respiratory infection
44
;45. Those receiving 
immediate antibiotics were much more likely to indicate they would re-attend with their next 
eye infection than those receiving no antibiotics or a delayed script. 
Delayed prescribing gives the GP the opportunity to discuss the natural history of  acute 
infective conjunctivitis with the patient. My qualitative work
109 indicated that patients lack of 
awareness of  the self-limiting nature of  acute infective conjunctivitis was an important reason 
for them attending for antibiotics. It also revealed that they were happy with a delayed 
prescription approach and were comfortable with the decision to start the antibiotics or not. 
The provision of  a patient information leaflet or performing an eye swab did not affect any of 
the main outcome measures. However, patients were more satisfied with the information 
provided and possibly more satisfied with the consultation, and felt they had their concerns 
better addressed, when a leaflet was given. This suggests that providing a patient information 
leaflet within the GP consultation for acute infective conjunctivitis may be more beneficial 
than a brief  explanation of  the natural history and symptomatic management. Past studies 
assessing the effectiveness ofleaflets in general practice
46
;70-72;113 have shown variable results, 
with some showing a change in consulting behaviour or antibiotic use after receiving a 
leafleeo
;71. However, some show little or no effect on outcome measures
46
;72. Providing a 
leaflet specific to the presenting condition within the consultation, as was done in my trial, 
seems to be most likely to have an effect
68
. A possible explanation for the lack of  effect on the 
main outcome measures in this trial (particularly the belief  in the effectiveness of  antibiotics 
for acute infective conjunctivitis and intention to re-attend with subsequent episodes of 
conjunctivitis questions) is that the leaflet used in my study was deliberately neutral as to the 
best management strategy for acute infective conjunctivitis.  This was necessary as it was 
being given to all three treatment groups. If  the wording of  the leaflet were changed, in light of 
the new research evidence
28
;41;42, to highlight the marginal benefit for antibiotics and the 
possibility of  a 'wait and see' approach then a greater effect may be seen. 
Undertaking an eye swab had no effect on the main outcome measures. However, patients who 
had  an  eye  swab  seemed  to  be  more  worried  about  their eye  problem.  The  borderline 
104 significant interaction between immediate prescribing and having an eye swab for the duration 
of moderate symptoms and the significant interaction for  mild symptoms,  suggests  further 
studies could explore the hypothesis that an investigation may create uncertainty in patients 
minds and possibly effect  perceived  symptom resolution
114
;115. In everyday general practice 
eye swabs are rarely used  19 because of  the cost and time delay in receiving a result. However, 
diagnostic testing prior to prescribing
1l6 has been suggested for a range of illness as a way of 
reducing  antibiotic  use.  If bacterial  conjunctivitis  could  be  distinguished  from  viral 
conjunctivitis, prescribing could potentially be reduced by 50% - so is  it worth considering 
increased use of eye  swabs  for  acute infective  conjunctivitis? My trial  and  Roses'  trial
41 
showed no difference in clinical cure rates between antibiotic and no antibiotic groups, even in 
those with a positive bacterial swab result. However Rietvelds
28 trial did show a greater effect 
of antibiotics  in  those who  are  swab  positive for  bacteria.  Taking the  marginal effect of 
antibiotics, the potential for increased worry, and the cost and delay of  performing swabs into 
account, it would not seem appropriate to recommend increased use of eye swabs for acute 
infective conjunctivitis in general practice. 
The  uncertainty as  to  whether antibiotics  have  a greater  benefit in those  with  a bacterial 
aetiology also raises the question as to whether a symptom score to discriminate bacterial from 
viral conjunctivitis has any value. If  the benefit of  antibiotics is marginal, and the condition is 
self-limiting, then discriminating bacterial from viral conjunctivitis becomes unnecessary. 
Re-attendance at the GP surgery at two weeks was less in the delayed antibiotic prescription 
group than the immediate and no prescription groups. Additionally, there was a borderline 
significant reduction in re-attendance in the year following the initial consultation for the 
delayed prescription group compared to the other groups. This suggests that a delayed 
prescription policy may reduce actual re-attendance rates in the longer term (consistent with 
the results from the 'intention to re-consult with future episodes of  conjunctivitis' question in 
the patient questionnaire and with the results of  previous studies
37
;45). Thus delayed 
prescribing may have longer term benefits on GP workload and patient self-care for acute 
infective conjunctivitis. A larger trial would be needed to confirm this. 
105 and meta-analysis
42 still found a benefit at days 2 to 5 for topical antibiotics after 
incorporation of  these two new trials (RR=  1.24, 95% CI 1.05 to 1.45). 
My trial has results consistent with the Cochrane review
42
, showing some benefit for topical 
antibiotics for acute infective conjunctivitis. However, the benefit is relatively small and acute 
infective conjunctivitis is a self-limiting minor illness. 
An important feature of  my trial is its ability to look at patients' behaviour in response to the 
different management strategies as this should give an indication of  what would happen if  GPs 
changed their management of  acute infective conjunctivitis in light of  the new research 
evidence. No initial offer of  antibiotics may seem like a reasonable strategy, but GPs may find 
resistance to this among patients who have been used to receiving topical antibiotics. 
Additionally, my study shows that 30% of  patients randomised to no initial offer of  antibiotics 
ended up receiving antibiotics and that they re-attended more in the two weeks following the 
initial consultation that those receiving a delayed prescription. 
Issuing a delayed prescription provides an opportunity to discuss the natural history of  acute 
infective conjunctivitis and the new research results
28
;41;42 (regarding the limited potential 
benefit from antibiotics) with the patient. The patients' 'knowledge gap' (their lack of 
awareness that acute infective conjunctivitis is self-limitinglO) can be addressed. Providing 
this information would allow them to make a more informed choice as to whether they would 
prefer to have antibiotics or not. Delayed prescribing also empowers the patient by allowing 
them to decide whether to and/or when to start the medication. The qualitative study showed 
that patients found the delayed prescription strategy acceptable and that that they were 
comfortable with the decision to start the antibiotics or not. 
Thus, a delayed prescription seems an appropriate strategy for GPs to adopt It  provides 
similar symptom control to immediate prescribing but has the advantage of  reducing antibiotic 
use by nearly 50%. Additionally, it shows no evidence of  medicalisation, and reduces re-
attendance in the short term compared with no offer of  antibiotics. 
A patient information leaflet had no affect on the main outcomes from the trial but did seem to 
increase satisfaction with the consultation, the amount of  information received and the 
patients' perception that the doctor dealt with their concerns. It  also received positive 
responses in the qualitative study. Thus, it would seem reasonable that GPs should use a 
leaflet alongside the delayed prescribing approach. 
108 cellulitis, keratitis and panophthalmitis are mentioned in the literature. Antibiotic prescribing 
has been widespread and if  this is to be reduced, then the possibility that complications may 
increase should be considered. The most appropriate method to investigate rare occurrences 
such as this would be a case control study. The cases and the controls should both be taken 
from a general practice population so a database such as the General Practice Research 
Database (GPRD) would be appropriate. The GPRD collects prescribing, diagnostic and 
background data from about 3 million GP patients in the UK. 
Further research is also needed to explore the area of  school and nursery attendance in 
children with acute infective conjunctivitis, as some of  these institutions have exclusion 
policies for those with conjunctivitis and this may influence parents' acceptance of  a delayed 
prescribing or no prescribing approach. Presumably an exclusion policy is designed to prevent 
spread of  acute infective conjunctivitis to other children, but is this necessary for a minor self-
limiting illness? - most schools and nurseries do not exclude children with a common cold. 
The Health Protection Agency website states that there is no need for exclusion
95
. A study 
could survey schools and nurseries to assess their current policies regarding acute infective 
conjunctivitis and then provide information and follow up to see if  policies change. 
Additionally, a survey of  pharmacists regarding their knowledge of  the management of  acute 
infective conjunctivitis and their current recommendations to customers would be valuable as 
they are an important source of  patient information and they can now offer over the counter 
topical chloramphenicol. 
Research into acute infective conjunctivitis must be taken in the context of  the conditions of 
the time, i.e. the level of  infections in the community, the organisms causing those infections 
and the management of  the infections by professionals and lay people. All these aspects can 
change over time. Ongoing programmes of  research will be required to cope with the dynamic 
nature community infections. 
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III Appendix 1  GP Survey about Acute Infective Conjunctivitis 
GP NaIlle ------------------------------------ Practice naIlle-------------------------------------------------
Male / F  emale------ Years as a GP -------- Practice list size-----------------------------------------------
No. of  GP sessions worked per week -------- MRCGP?  YIN 
Do you have any specialist experience in ophthalmology? YIN If  Yes - what? ----------------------
1)  What features do you use to diagnose acute infective conjunctivitis? 
Red eye  YIN  Eye discharge  YIN 
Eyelashes stuck together in morning  YIN  Irritation!  grittiness of  eye  YIN 
Swollen eye lid  YIN  History of  contact with conjunctivitis  YIN 
Conjunctival injection  YIN  Conjunctival Oedema  YIN 
Other  YIN  please specuy----------------------------------------------------------------------
2)  What examination do you usually perform? - if  any 
Visual inspection YIN  Corneal staining  YIN 
Ophthalmoscopy YIN  Other YIN please specify---------------------------------------------
3)  How confident do you feel with diagnosing acute infective conjunctivitis? 
very confident / confident / neutral/not very confident / not confident 
4)  Do you feel you can discriminate viral from bacterial infection?  YIN 
If  yes: Do you use: 
History ofa 'cold' YIN 
Other features of  the history YIN If  yes what?  -------------------------------------------------------
Type of  discharge (ie watery or sticky)  YIN 
Amount of  discharge  YIN 
Bilateral versus unilateral infection  YIN 
Other YIN if  yes please specify-------------------------------------------------------------------------
5)  What proportion of the  cases  of acute  infective  conjunctivitis  that you  see  do  you think  are 
bacterial?  <10%  10-29%  30-49%  50-69%  70-89%  >90% 
6)  Do you usually prescribe for this condition? Y  / N 
If  yes:  What do you usually prescribe first line and for how long?--------------------------------
Are there patients where you are happy not to prescribe?  YIN 
If  Yes: In what proportion of  patients? <10%  10-29%  30-49% 50-69%  70-89%  >90% 
What are the characteristics of  these cases?--------------------------------------------------------
7)  Do you ever use a 'delayed prescription' strategy for infective conjunctivitis? YIN 
If  Yes:  Inwhatproportionofpatients?<10%  10-29%  30-49%  50-69%  70-89%  >90% 
8)  Do you ever take eye swabs for acute infective conjunctivitis?  Y/ N 
If  Yes: In what proportion of  cases?  <10%  10-29%  30-49% 50-69%  70-89%  >90% 
What are the commonest reasons for doing so?  --------------------------------------------------------------------
9)  Do you have a patient information leaflet about acute infective conjunctivitis? YIN 
rfYes: What proportion do you give itto? <10%  10-29%  30-49%  50-69%  70-89%  >90% 
Please use the back of  this sheet for any other comments you have about the management of 
acute infective conjunctivitis. 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
Please return in the Freepost envelope provided to:  Dr  Hazel Everitt, MRC Fellow, 
Primary Medical Care, Aldermoor Health Centre, Aldermoor Close, SouthaIllpton, SO 16 5ST 
112 Appendix 2: Qualitative Study Information Sheet and Consent form 
113 University 
of Southampton 
EYE INFECTION STUDY 
Patient information sheet 
We  feel  it  is  important to  find  out about patients views  about illnesses.  This research  project is 
trying  to  find  out what you  feel  about  eye  infections.  This  includes  your concems  about  eye 
infections, the sorts of available treatment and what you feel about the way your infection has been 
managed. 
The  study involves taking  part in  a confidential tape-recorded  interviewer with  a researcher.  The 
information  will  be  recorded  for  research  purposes  only  and  will  only  be  identified  by  an 
identification number. The tape recording of  your interview will be destroyed within one year. 
All  the  information  that you  give  us  will  be  keep  fully confidential.  Even  your GP  will  not see  it. 
Your!your child's name will not appear on any documents or reports. 
You can withdraw yourself/your child from the study at any time without it affecting you!your child's 
treatment in any way. 
If you have any queries please contact: 
Hazel Everitt 
Primary Medical Care, 




(Tel 02380 241079 - 24 hr ansaphone) 
Date:------------ Doctors Name: -------------
Name: MrslMrlMiss------------------





114 Appendix 3:Conjunctivitis Qualitative Study Interview Guide 
This guide was continually updated and adapted as interviewing progressed. It  acted as an aide 
memoir to remind me of  areas that might be interesting to pursue. This version is from 
19/01101 approximately halfway through the interviewing and thus includes areas that I 
thought may be interesting prior to starting the interviews but also much more that emerged as 
the interviews progressed. 




Describe eye problem went to doctor with 




Self  medication 
Concerns/worries 
Preceeding health status 
Relationship with Dr 
Expectations from consultation 
Satisfaction with consultation 
Advice given by GP 
What if  no prescription?/delayed 
Cause of  infection-virallbacterial? Is it important to know? 
How see illness- serious or minor- what would happen ifnot treated? 
Why went to dr/nurse?  - decision to consult 
Advice 
treatment 
Decision to consult for oneself  or for child - decisions 
Confidence with advice from doctor/nurse 
Treatment - What is in ointment /drops? 
How does it work 
Is it important to know how it works? 
When is it important to know? 
What would happen if  not treated -natural hx of  disease 
Difficulty accessing treatment 
Getting appt/script 
Concerns re wasting GPs time 
?nurse clinic 
115 Appendix 5: Trial Protocol 
Conjunctivitis Trial Protocol 
1.1 Title 
Open Randomised Controlled Trial of  Management Strategies for Acute Infective 
Conjunctivitis in General Practice 
1.2 Principal Investigator 
Dr Hazel Everitt 
Primary Medical Care 




Tel: 023 80241079 
Email: hae1@soton.ac. uk 
Fax: 023 80701125 
2  The need for a trial 
Patients with acute infective conjunctivitis are commonly seen in general practice.  2 
t05 % of  general practice consultations are related to eye conditions and approximately 
40% of these are concerned with conjunctivitis. Thus, on average, GPs see a patient 
with infective conjunctivitis every week. However, the most appropriate management 
strategy for GPs to employ for acute infective conjunctivitis is uncertain. 
Traditionally,  bacterial  conjunctivitis  has  been  treated  with  topical  antibiotic 
preparations  (eg  chloramphenicol eye  drops).  The  difficulty  distinguishing bacterial 
from viral conjunctivitis has meant that most patients who present with conjunctivitis 
are treated with antibiotics empirically.  Thus,  a significant number of patients  with 
viral conjunctivitis are likely to be given antibiotics unnecessarily. 
Even in confmned bacterial conjunctivitis there is some uncertainty regarding the role 
of antibiotics. Bacterial conjunctivitis  is  as  a self-limiting illness,  resolving  in  most 
cases in 5 to 7 days without treatment.  Antibiotics have been used in an attempt to 
reduce  the  duration  and  severity  of symptoms  and the  likelihood  of relapse  and 
complications (eg orbital cellulitis).  However, the evidence for this  is  weak,  as  few 
randomised controlled trials have been published comparing the effect of antibiotics 
with placebo. Most of  the trials have taken place in the USA in secondary care, none in 
general practice. 
Further evidence is needed to confirm the most appropriate management strategy for 
acute infective conjunctivitis. 
2.1 Problem to be addressed 
To  assess  the  effect  of  common  management  strategies  for  acute  infective 
conjunctivitis in general practice. 
2.2 What is the hypothesis to be tested? 
l18 The  Null  hypothesis  is  that for  patients  presenting  to  general  practice  with  acute 
infective conjunctivitis, there is no difference in clinical outcome or belief in antibiotic 
effectiveness  in  those  treated  with  immediate antibiotics  compared to  management 
without antibiotics or with delayed antibiotics. 
2.3 Why is a trial needed now? 
It is now recognised that use of antibiotics should be restricted as  far  as  possible to 
cases of proven need and benefit. The emergence of increasing resistance in common 
bacteria and the acknowledgement of the potential harmful effects of antibiotics has 
focused attention on reducing antibiotic prescribing wherever possible, particularly for 
acute self-limiting infections. 
Also, concern has emerged regarding the possible medicalising effects of prescribing 
antibiotics - prescribing reinforcing patients belief in antibiotics and the intention to 
seek medical help (as has been demonstrated for prescribing in sore throat). This may 
lead to increased pressure on already stretched primary care resources. 
2.4 Has a systematic review been carried out and what where its findings? 
A  Cochrane  review  looking  at  antibiotics  for  acute  bacterial  conjunctivitis  was 
published in April 1999. It  found 3 RCTs that fulfilled eligibility to be included in the 
review.  They  concluded  that:  'Acute  bacterial  conjunctivitis  is  frequently  a  self-
limiting condition but the use of  antibiotics is associated with significantly improved 
rates of  clinical cure and microbiological eradication. These results however cannot be 
generalised to a primary care based population.' 
2.5 How will the results of  this trial be used? 
This trial will help to clarify which strategies are most appropriate for the management 
of  acute infective conjunctivitis in general practice. 
2.6 Please detail any risks to the safety of  participants involved in the trial 
None 
3 The Proposed Trial 
3.1 What is the proposed trial design? 
The trial will be an open randomised controlled trial with a 3x2x2 factorial design. 
3.2 What are the planned trial interventions? 
The patients will be randomised to receiving one of 3 treatments: 
4)  topical antibiotic eye drops for 7days. 
5)  no prescription. 
6)  a delayed prescription of  antibiotic eye drops after 3 days. 
These groups will be further randomised to receive a patient information leaflet (which 
has been developed in the qualitative study allied to this trial). 
Half the patients in  each group will have eye swabs sent for culture.  This will give 
microbiological information about the cohort. 
3.3 What is the proposed duration of  treatment period? 
119 Treatment  as  detailed  above.  The  diary  will  be  used  to  record  symptoms  for  a 
maximum of 14days 
3.4 What are the planned inclusion/exclusion criteria? 
Inclusion  criteria:  Patients  aged  I  year  and  over  presenting  with  presumed  acute 
infective conjunctivitis (red, inflamed discharging eyes) to their general practitioner or 
practice nurse. 
Exclusion criteria:  Patients who are systemically unwell and require oral antibiotics, 
patients  who  have  had  antibiotics  in  the  previous  2  weeks,  patients  with  chronic 
infective eye disease eg blepharitis and patients having recently had eye surgery ie in 
the last one month. 
3.5 What are the proposed outcome measures? 
Primary:  3 primary outcomes: 
Symptom severity score (mean item score for 5 main symptoms over 
first 3 days of  the diary) - Main outcome 
Duration of  moderately severe symptoms 
Belief  in the efficacy of  antibiotics for conjunctivitis 
Secondary:  Duration of  minor symptoms 
Relapse of  symptoms 
Compliance with the treatment 
Use of  antibiotics 
Perceived importance of  seeing the doctor. 
3.6 Will Health service research issues be addressed? 
Health economic issues are not being addressed 
Quality of  life measures are being assessed in the diary. 
3.7 What is the proposed frequency/duration of  follow up? 
Participants will complete diaries for a maximum of  14 days after recruitment. 
3.8 How will the outcome measures be measured at  follow-up? 
GP information sheet 
The  general  practitioner will  fill  in  a  documentation  sheet during the consultation 
showing duration of  illness, signs and symptoms and treatment offered. 
Patient Questionnaire and Diary 
Patients will be given a daily dairy in which to record symptoms and will be asked to 
continue  the  diary  until  they  are  both  free  of symptoms  and  have  finished  their 
medication (up to a maximum of 14 days). In the case of children under 12 the parent 
will  be  asked  to  complete  the  diary  (as  used  successfully  in  previous  studied 
undertaken by this group). Parental recording of  child symptoms has been shown to be 
valid in previous trials. The design of the diary is similar to those used in previous 
trials.  The symptoms  recorded  in the diary has been determined by a  search of the 
literature and from  information gathered in the associated qualitative study (face and 
content validity). Construct validity of  the diary will be checked by asking 30 patients 
to complete a MYMOP questionnaire at Day1  and Day3 - thus enabling comparison of 
the diary with a validated measure of symptom severity recording.  Patients will  be 
120 contacted within 3 days of  the consultation to check that there are no problems filling 
in the diary. 
Patients will also be asked to answer written questions using a validated Likert scale at 
the beginning of  treatment - regarding worries, treatment option and satisfaction - and 
at the end - regarding antibiotic use, perceived efficacy, future intentions and time off 
work or school. 
It is anticipated (based on experience from similar trials within the group) that at least 
75  % of the diaries  will be returned.  Patients who  fail  to return the diary within 2 
weeks of entry to the study will be telephoned to ask the questions addressed by the 
diary. The validity of  information gathered by questionnaire and by telephone has been 
shown to be comparable in this type of  trial. 
3.9 What are the proposed practical arrangements for allocation participants to the trial 
groups? 
Participants will be randomised by the opening of  a sealed numbered opaque envelope 
in the consultation as to which treatment they will receive (used successfully with no 
evidence of selection bias  in previous  studies  undertaken by this  group).  Balanced 
randomisation will be used to ensure equal sample sizes in each group. 
3.10 What are the proposed methods for protecting against other sources of  bias? 
Blinding is  not appropriate for  this trial.  An open trial design is  essential to  assess 
patients' perceptions and choices in response to different management strategies. It is a 
design that closely represents the behaviour every  day general practice (this type of 
trial has been used successfully to research antibiotic prescribing in sore throat, otitis 
media  and  cough  within this  research  group).  The main disadvantage  of using this 
approach is the possibility of bias due to the placebo effect. However it has shown in 
previous trials that the use structured advice packages to enable the general practitioner 
to support each proposed strategy means that the general practitioner can function as 
the placebo in each group. 
3.11 What is  the proposed sample size and what is the justification for the assumptions 
underlying the power calculations? 
The original calculations based on information on symptom duration and the effect of 
antibiotics from  the literature,  estimated that a sample size of 200 patients will be 
required to detect a 1 day difference in symptom resolution and a 25% difference in 
belief in  antibiotics.  This  was  calculated  by  nomogram  for  multiple  groups  in a 
factorial trial for the symptom resolution and Spida 1.6 version computer package for 
the belief in antibiotics. Because of the uncertainty behind the assumptions made for 
the sample size calculation (lack of  available evidence) a sample size of300 was set as 
the working target. 
Assessment of  severity and duration data from 126 diaries (Jan 2004) has allowed 
recalculation of  the sample size.(using NQuery multiple group sample size program) 
For an alpha ofO.O!: 
Duration moderate symptoms (a day between each group) 234 are needed 
Severity of  symptoms (0.33 between each group) 264 are needed 
Beliefs in antibiotics (15% between each group) 246 are needed 
121 After discussion with the TSC a sample size of260 to 300 will be aimed for to allow 
for some sub group analysis. 
3.12 What is the planned recruitment rate? 
75 patients  per year for 4 years =  300 participants. 
3.13 Are there likely to be any problems with compliance? 
Unlikely 
3.14 What is the likely loss to follow up rate? 
.  It is anticipated (based on experience from similar trials within the group18) that at least 
75 % of  the diaries will be returned (thus a loss to follow up of25%). 
3.15 How many centres will be involved? 
One centre - Southampton - but many GP practices (50 to 100) will recruit patients 
from Southampton, Salisbury, Portmouth and Dorset LREC areas. 
3.16 What is the proposed type of  analysis? 
Data will  be  analysed  on an  intention to  treat basis  by logistic  regression  for  the 
factorial  study  for  discrete  outcomes  (eg  %  belief in  antibiotics)  and  Anova  for 
continuous outcomes (eg symptom resolution). 
3.17 What is the proposed frequency of  the analysis? 
Analysis will occur after data collect is complete. 
3.18 Are there any planned sub group analyses? 
Yes.  Regression  modelling  will  be  used  to  determine  factors  that predict  adverse 
outcome  (severe/prolonged  symptoms)  and  assess  if this  subgroup  predicts  benefit  from 
antibiotics.  Potential  factors  may  include  severity  of presenting  symptoms,  bilateral  vs 
unilateral disease, presence/absence of  other (non eye related) symptoms, age. 
3.19 Has any pilot study been carried out using this design? 
Yes.  The  other  trials  successfully  undertaken  by  this  group  (eg  sore  throat,  OtIt1S 
media) have had very similar design.  Also small pilot to assess paperwork and swab 
analysis was undertaken. 
4 Trial Management 
4.1 What are the arrangements for day to day management of  the triaL 
Dr Hazel  Everitt  is  responsible  for  day to  day  management of the trial  including 
recruiting GPs , managing paperwork and data handling. 
4.2 What  will be the responsibilities of  the applicants? 
Dr Everitt -Day to day management of  the trial 
4.3 What  will be the responsibility of  the staff  employed on the grant? 
Dr Everitt -Day to day management of  the trial 
4.4 What will be the role of  the named collaborators? 
122 N/A 
4.5 Who is the trial statistician? 
Professor Paul Little is supervising the statistics for the trial. 
4.6 Trial steering committee 
Prof  Chris Butler (chair) Cardiff University, Dr Hazel Everitt (trial manager) 
Southampton University, Prof  Paul Little (trial supervisor) Southampton University, 
Rebecca Cannings (statistician) Cardiff University, Dr Alastair Hay (independent 
committee member) Bristol University. 
Ethical approval 
Patients will give informed consent to be included in the trial (parents will give consent 
for  children under 16yrs).  Competent children (ie those aged 10-16yrs) will also be 
asked for consent along with their parent and will sign the consent form 
Full  Ethical  approval  has  been  sought  and  gained  for  this  research  project from 
Southampton (no:  267/99), Portsmouth (no:  09/99/894) and  Salisbury (no:  SA27/99) 
and Dorset (no:46/03/S) LRECs. 
Trial registration number: ISRCTN32956955 
123 Appendix 6: Patient information sheet for the Randomised Controlled Trial 
124 University 
of Southampton 
EYE INFECTION STUDY 
Patient information sheet 
This  research  project is  trying  to  find  out what you  feel  about  the  different sorts  of available 
treatment and advice GPs give about eye infections. It will also give us valuable information about 
how quickly you/your child  gets better from  eye  infections,  what other symptoms you/your child 
experienced and what causes eye infections. 
What the study involves for you: 
answer a brief questionnaire today 
you/your child may be asked to have an eye swab performed today by your GP 
complete the diary of you/your child's symptoms and answer a few questions and then return  it 
in the Freepost envelope provided 
the research assistant may ask you to consider talking confidentially about  concerns you have 
about eye infections: this information will be  recorded for research purposes only and remains 
strictly confidential 
your/your childs' notes may be checked by the researcher after the study to see if  you have had 
any fu rther problems with eye infections 
At any time during the study you are free to withdraw yourself/your child without giving any reason 
and without affecting your/your child's future treatment in any way. 
All  the information that you give  us will be  keep fully confidential.  Even  your GP will  not see the 
diary or questionnaires. Your/your child's name will not appear on any documents or reports. 
If you have any queries please contact: 
Hazel Everitt 
Primary Medical Care, 




(fel 02380 241079 - 24 hr ansaphone) 
March 2003 
125 Appendix 7: Consent form for the Randomised Controlled Trial 
126 LREC number: 
Patient 10 no: __  _ 
Please initial box:-
University 
of  Southampton 
EYE INFECTION STUDY 
CONSENT FORM 
1.  I confirm that I have read  and  understand the information sheet for the eye infection study and 
have had an opportunity to ask questions. 
2.  I understand that my participation is voluntary and that I am free to  withdraw myself/my child 
from the study at any time, without giving any reason, without my medical care or legal rights 
being affected. 
3.  I agree to take part in the above study. 
Or I agree for my child _________  to take part in the study. 
Your name MrlMrs/MisslMs __________  _ 
Yoursignature ___________  Date ___  _ 
Child's signature (if appropriate) __________  _ 
Address ________________________  ___ 
Postcode _______  Telephone no. ______  _ 
Name of person taking consent _________  Date ____  _ 
Signature of person taking consent __________  _ 
March 2003 
127 Appendix 9: 'Not Entered' Book Information 
GPs or Practice nurses were asked to note any patients presenting with acute infective 
conjunctivitis that were not entered into the trial. They noted the patients age, sex, the reason 
for not entering the trial (see list below) and the severity of  the conjunctivitis (conjunctival 
injection and amount of  eye discharge - scoring system below) 
REASON FOR PATIENT NOT ENTERING STUDY 
1)  No time (doctor) 
2)  Patient refused 
3)  Parental anxiety 
4)  Patient too unwell 
5)  Antibiotics for conjunctivitis in last 2 weeks 
6)  Problems following previous conjunctivitis 
7)  Chronic infective eye condition (eg blepharitis) 
8)  Recent eye surgery (in last month) 
9)  Other 
SEVERITY OF THE EYE INFECTION - Please score the level of  conjunctival injection and 
the amount of  eye discharge 
O=normal, 1  =very little, 2=slight, 3=moderate, 4=bad, 5=very bad, 6=as severe as it could be 
129 Appendix 10: GP Initial Clinical Signs Sheet from the Randomised Controlled Trial 
EYE INFECTION STUDY 
Initial Clinical Signs Sheet 
Patient's Name _________  _ 
Date of Birth  _,_,_  Date Entered into study _,_,_ 
1.  Duration of eye infection (days) 
2.  Which eye affected?  Right' Left' Both 
3.  Clinical signs present on examination: 
Please indicate the severity ofthe sign by placing a number in each box from 0 to 6. 






Conjunctival injection  D 
Conjunctival oedema  D 
Subconjunctival haemorrhage  D 
Eye discharge 
If present, is the discharge: i) Clear /yellow /green 'bloody 
ii)  Sticky' watery 
iii)  large amount! small amount 
e.  Neck lymphadenopathy 
If present, is it:  (please circle)  Pre-auricular' cervical/ other 
f.  Other symptoms present with this illness?  D 
Please specify ~  ___  ---,,..---,,--_,,--_~~  _____  _ 
(eg sore throat, cough, fever, headache) 
4.  What is your clinical diagnosis? 
(Please tick box) 
Bacterial conjunctivitis 
Viral conjunctivitis 
Other ______  _  B 
5.  How confident are you of  the diagnosis?  II 
O=not at all, 1  =very little, 2= slightly, 3 =moderately~ite,  5=very, 6=certain. 
Thank you! 
130 10 No: __  _ 
ADVICE SHEET 2 
Please follow this advice sheet as near verbatim as possible.  After patient has left please tick only 









1.  This is an eye infection 
2.  Sticky eyes can be relieved 
by bathing with cooled 
boiled water 
Most patients get better 
without antibiotic drops 
Antibiotic drops may 
cause side effects 
Antibiotic drops may still be 
prescribed if: 
Follow-up 
To recap most get better 
so try and wait 3 days 
Any questions? 
Suggested wording 
known as conjunctivitis. Usually your/your child's 
body will fight the infection and heal itself over the 
next week without the need for antibiotics. 
Conjunctivitis often causes sticky eyes - especially in the 
mornings. This is not harmful but may be irritating. 
Your/your childs' eyes may be cleaned as often 
as is required with a piece of  wet cotton wool. 
Antibiotics are not usually needed for eye infections. They 
are not painkillers. 
can cause allergy and can lead to antibiotic resistance 
you are not starting to improve in 3 days (explain that a 
red eye and discharge for a few days is normal and 
does not mean antibiotics are needed). 
A prescription will be left for you in reception. 
(Chloramphenicol eye drops 0.5% 10ml, 2 drops in the 
affected eye every 2 hours for 2 days then 2 drops four 
times a day, continue for 48hours after healing) 
if you/your child have pain in the eye (opposed to a gritty 
feeling) or increasing swelling or redness around the 
eye or your/your childs' vision is affected please come of 
a check-up appointment. Also come back if it is not 
settling after one week 
before collecting the prescription. 
NB Remember to state you are in the eye infection 
study if you collect a prescription. 
Can  J put your mind at rest about any concerns or 
questions you have? (Please make a note of  these below) 
Did the patient leave the surgery with a prescription for antibiotics?  Y  N 
How well did you feel the patient accepted the advice strategy? 
Extremely  Very  Moderately  Slightly  Not very 
well  well  well  well  well 
DOD  0  0 
Not at all 
well 
D 
Make a note on patient's notes that they have been entered into the study and that they have 
been given Adv Pkg 2. 
(  . 
Please include this sheet with the Initial Clinical Signs sheet and Consent form and return In 
the stamped addressed envelope provided. IDNo: __ 
ADVICE SHEET 3 
Please follow this advice sheet as near verbatim as possible.  After  patient has left please tick only 






This is an eye infection 
Sticky eyes can be relieved 
by bathing with cooled 
boiled water 
Most patients get better 
without antibiotic drops 
Antibiotic drops can also 




known as conjunctivitis. Your/your child's body will fight 
the infection and heal itself over the next week without the 
need for antibiotics. 
Conjunctivitis often causes sticky eyes -especially in the 
mornings. This is not harmful but may be irritating and 
may be cleaned as often as is required with a piece of wet 
cotton wool 
Antibiotics are not needed for eye infections. They 
are not painkillers. 
can cause allergy, and can lead to antibiotic resistance. 
if you/your child have pain in the eye (opposed to a gritty 
feeling) or increasing swelling or redness around 
the eye or the vision is affected please come for a 
check up. (explain that a red eye and discharge 
for a few days is normalj. Also come back if it is not 
settling after one week. 
Can I put your mind at rest about any concerns or 
questions you have? (Please make a note of these below) 
Did the patient leave the surgery with a prescription for antibiotics?  Y  N 
















Not at all 
well 
o 
Make a note on patient's notes that they have been entered into the study and that they have 
been given Adv Pkg 3. 
Please include this sheet with the Initial Clinical Signs sheet and Consent form and return in 
the stamped addressed envelope provided. IDNo:_ 
ADVICE SHEET 6 
Please follow this advice sheet as near verbatim as possible.  After  patient has left please tick only 




This is an eye infection 
Sticky eyes can be relieved 
by bathing with cooled 
boiled water 
Most patients get better 
without antibiotic drops 
Antibiotic drops can also 
cause side effects 
I would like to take a 




known as conjunctivitis. Your/your child's body will fight 
the infection and heal itself over the next week without the 
need for antibiotics. 
Conjunctivitis often causes sticky eyes -especially in the 
mornings. This is not harmful but may be irritating and 
may be cleaned as often as is required with a piece of wet 
cotton wool 
Antibiotics are not needed for eye infections. They 
are not painkillers. 
can cause allergy, and can lead to antibiotic resistance. 
This will be sent to the laboratory to see if there 
are any bacteria. The result will be available in 5-7 days 
time. 
if you/your child have pain in the eye (opposed to a gritty 
feeling) or increasing swelling or redness around 
the eye or the vision is affected please come for a 
check up. (explain that a red eye and discharge 
for a few days is normalj. Also come back if it is not 
settling after one week. 
Can  I put your mind at rest about any concerns or 
questions you have? (Please make a note of these below) 
Did the patient leave the surgery with a prescription for antibiotics?  Y  N 
















Not at all 
well 
o 
Make a note on patient's notes that they have been entered into the study and that they have 
been given Adv Pkg 6. 
Label the eye swab and microbiology  form (include patients name, date of  birth, address & 
IDno) and place in todays transport to microbiology at SGH. Store at room temperature. 
Please include this sheet with the Initial Clinical Signs sheet and Consent form and return in 
the stamped addressed envelope provided to Primary Medical Care. 10 No: ___  _ 
ADVICE SHEET 11 
Please follow this advice sheet as near verbatim as possible.  After  patient has left please tick only 




1.  This is an eye infection 
2.  Sticky eyes can be relieved 
by bathing with cooled 
boiled water 
Most patients get better 
without antibiotic drops 
Antibiotic drops may 
cause side effects 
Antibiotic drops may still be 
prescribed if: 
Suggested wording 
known as conjunctivitis. Usually your/your child's 
body will fight the infection and heal itself over the 
next week without the need for antibiotics. 
Conjunctivitis often causes sticky eyes - especially in the 
mornings. This is not harmful but may be irritating. 
Your/your childs' eyes may be cleaned as often 
as is required with a piece of wet cotton wool. 
Antibiotics are not usually needed for eye infections. They 
are not painkillers. 
can cause allergy and can lead to antibiotic resistance 
you are not starting to improve in 3 days (explain that a 
red eye and discharge for a few days is normal and 
does not mean antibiotics are needed). 
A prescription will  be left for you in reception. 
(Chloramphenicol eye drops 0.5% 10ml, 2 drops in the 
affected eye every 2 hours for 2 days then 2 drops four 
times a day, continue for 48hours after healing) 
o  6.  Follow-up  if you/your child have pain in the eye (opposed to a gritty 
feeling) or increasing swelling or redness around the 
o  7. 
Os. 
To recap most get better 
so try and wait 3 days 
Here is a patient 
information sheet 
Any questions? 
eye or your/your childs' vision is affected please come of 
a check-up appointment. Also come back if it is not 
settling after one week 
before collecting the prescription. 
NB Remember to state you are in the eye infection 
study if  you collect a prescription. 
It contains information to help you manage conjunctivitis. 
Please read it carefully and keep it in a safe place. 
Can I put your mind at rest about any concerns or 
questions you have? (Please make a note of  these below) 
Did the patient leave the surgery with a prescription for antibiotics?  Y  N 
How well did you feel the patient accepted the advice strategy? 
Extremely  Very  Moderately  Slightly  Not very 
well  well  well  well  well  o  0  0  0  0 
Not at all 
well 
o 
Make a note on patient's notes that they have been entered into the study and that they have 
been given Adv Pkg 11.  i 
Please include this sheet with the Initial Clinical Signs sheet and Consent form and return in 
the stamped addressed envelope provided to Primary Medical Care. IDNo: __ 
ADVICE SHEET 12 
Please follow this advice sheet as near verbatim as possible.  After  patient has left please tick only 





This is an eye infection 
Sticky eyes can be relieved 
by bathing with cooled 
boiled water 
Most patients get better 
without antibiotic drops 
Antibiotic drops can also 
cause side effects 
Follow-up 




known as conjunctivitis. Your/your child's body will fight 
the infection and heal itself over the next week without the 
need for antibiotics. 
Conjunctivitis often causes sticky eyes -especially in the 
mornings. This is not harmful but may be irritating and 
may be cleaned as often as is required with a piece of wet 
cotton wool 
Antibiotics are not needed for eye infections. They 
are not painkillers. 
can cause allergy, and can lead to antibiotic resistance. 
if you/your child have pain in the eye (opposed to a gritty 
feeling) or increasing swelling or redness around 
the eye or the vision is affected please come for a 
check up. (explain that a red eye and discharge 
for a few days is normal). Also come back if it is not 
settling after one week. 
It contains information to help you manage conjunctivitis. 
Please read it carefully and keep it in a safe place. 
Can I put your mind at rest about any concerns or 
questions you have? (Please make a note of these below) 
Did the patient leave the surgery with a prescription for antibiotics?  Y  N 
How well did you feel the patient accepted the advice strategy? 
Extremely 













Not at all 
well  o 
Make a note on patient's notes that they have been entered into the study and that they have 
been given Adv Pkg 12. 
Please include this sheet with the Initial Clinical Signs sheet and Consent form and return in 
the stamped addressed envelope provided to Primary Medical Care. 
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145 Diary of Symptoms 
Eye Infection Study 
Primary Medical Care 
University of Southampton • 
• 
• 
Eye Infection Study  DIARY OF SYMPTOMS 
Please fill in the diary below by choosing the most appropriate number from the code box 
for each question. 
You can see from the example below how to write the numbers in the boxes. Read down 
the list of symptoms for each day.  Fill in one day at a time.  Please complete the chart 
each evening.  The questions refer to how you (or your child) has felt during the last 24 
hours. Continue using the chart until you no longer have any symptoms.  If this diary 
is for your child, please fill in this diary together. 
IMPORTANT: All categories are for the last 24 hours. 
Please put your/your childs initials at the top of each page. 
Code box: 
o  = Normal/ not affected 
1 = Very little problem 
2 =  Slight problem 
3 =  Moderately bad 
4 = bad 
5 = Very bad 
6 = As bad as  it could be 
From the example given it can be  seen that the patient had a 'slightly' red eye; 'moderately bad' 
eye discomfort; waking with a sticky eye was 'very bad'  ; eye discharge during the day was 
'moderately bad': eye lid swelling was "very little problem"; vision was 'not affected' and the 
patient  found feeling unwell 'very little problem'. 
Example Day 
Red eye 
Eye discomfort or itchiness 
Woke with sticky eye 
Eye discharge during day 
Eye lid swelling 
Altered vision 
How unwell you/your child is feeling 
Survey  149  Page' 1 
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Eye Infection Study  Diary of Symptoms  WEEK 1 
Initials: 
Please fill in  0  0  M  M  Y  Y 
Date chart started CD  I CD  I CD 
IDno  ,..--.---.,--.------, 
office use only 
Day 1  Day 2  Day 3  Day4  Day 5  Day 6  Day 7 
Red eye  D  D  D  D  D  D  D 
Eye discomfort  D  D  D  D  D  D  D  or itchiness 
Woke with sticky eye  D  D  D  D  D  D  D 
Eye discharge  D  D  D  D  D  D  D  during the day 
Eye lid swelling  D  D  D  D  D  D  D 
Altered vision  D  D  D  D  D  D  D 
How unwell 
you/ your child feels  D  D  D  D  D  D  D 
Please continue the diary on the next page. When you/your child are completely better please go to the 
next section 
Survey· 148  Page: 1 
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Woke with a sticky eye 
Eye discharge 
during the day 
Eye lid swelling 
Altered vision 
How unwell you/your 









Diary of Symptoms  Week 2 
Day 9  Day 10  Day 11  Day 12 
D  D  D  D 
D  D  D  D 
D  D  D  D 
D  D  D  D 
D  D  D  D 
D  D  D  D 
D  D  D  D 





Day 13  Day 14 
D  D 
D  D 
D  D 
D  D 
D  D 
D  D 
D  D 
Page: 2 
111111111  • • 
• 
Eye Infection Study  10no 
office use only 
FINALLY after you/your child are completely better please answer the following 
questions by filling in the spaces or ticking the appropriate answer. 
01  Did you/your child experience a runny nose during the illness? 
yesD  DNO  If Yes, how many days? 
02  Did you/your child experience a cough during the illness? 
yesD  DNO  If Yes, how many days? 
03  Did you/your child experience a sore throat during the illness? 
yesD  DNa  If Yes, how many days? 
04  Did you/your child experience a diarrhoea during the illness? 
yesD  DNO  If Yes, how many days? 
05  Did you/your child have some form of pain/temperature relief e.g. paracetemol/calpoll 
Junifen? 
yesD  DNa 
If Yes, what was its name?  LI _____________  ----' 
06  Did you/your child use any medication/drops/ointment from the pharmacist? 
If Yes, what was its name?  I  yesD  DNa 
L-_____________  ~ 
07  Did you/your child bathe the affected eye/eyes in cooled boiled water? 
yesD  DNa  If yes, For how many days?  LI_-'------' 
08  Were you/your child given an antibiotic ointment/eye drop presc,iPttn?  yesD  Na 
09  If Yes to QS, did you/your child use the eye ointment/drops?  yesD  DNa 
010 If Yes to Q9, which day did you/your child start taking the eye ointment/drops (please state 
which day of the diary e.g. Day 3)  CD 
011 How many days did you/your child take them  for? 
I  I  I 
PLEASE TURN OVER AND CONTINUE WITH THE QUESTIONS 
Survey: 147  Page: 1 




Q 12 Do you think antibiotic eye ointment/drops are effective in treating eye infections? 




Very  Moderately 
effective  effective 







Not at all 
effective 
o 
Q 13 How likely are you to go/take your child to the doctor/nurse with a future eye infection? 
Extremely 












Q14 Did you take/your child take any time off work or school?  yesD  ONe 
Not at all 
likely 
o 
Q 15 if yes to Q12 which day did you/your child return.  (please state which day of  the diary 
e.g. day 4) 
Day 
Q 16 As a result of the visit to the doctor/nurse and advice you have been given, do you feel 
you are? 
much better  better  same or less 
Able to cope with your/your childs life? 0  0  D 
Able to understand your/your childs  0  0  D 
illness? 
Able to cope with your/your childs  0  D  0 
illness? 
Able to keep yourself/your child  D  0  D 
healthy? 
much more  more  same or less 
Confident about your/your childs  0  D  D 
health? 
Able to help yourself/your child?  0  D  D 
Please turn to the next page 
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017 Date of birth 
DO  MM  YYYY  OJ  ' OJ  'I  r--1"':-'1,---'---,1----' 
018Sex 
Male D  0 Female 
(If you are completing this questionnaire for your child please answer the following questions 
as they relate to  yourself) 
019 Marital Status:  Single 
Married (or living with partner) 
Widowed 
Divorced/separated 








021 At what age did you leave full time education? 
022 What are your highest formal educational qualifications? 
No formal educational qualifications 
CSEs/O'levels or similar 
A Levels (or similar) or ONC/OND 
Diploma (non degree) e.g.  HNC,  HND 
Degree 
Postgraduate Degree 
























Q23 Employment History 
Pick one statement below, that best explains your current employment status 
Full time employee 




Not in paid employment due to disability 
Not in paid employment due to long-term sickness 











What is the title or description of your current job OR the job you last had when your were in 
paid employment (please explain clearly) 






Please return this questionnaire in the freepost envelope provided. 
Thank you for all your help. 
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Date _____  _ 
1.  What proportion of patients with acute infective conjunctivitis that saw you during the 
trial period do you think were entered into the trial? 
<10%,  10-29%,  30-49%,  50-69%,  70-89%,  >90% 
2.  How many eligible patients that you asked about the trial refused to participate?--
3.  What were the main reasons for not entering patients into the trial? 
Please rank the below in order, 1 being the most likely and 10 the least 
No time (doctor) 
Patient under 1  yr old 
Patient refused 
Parental anxiety 
Patient too unwell 
Antibiotics for conjunctivitis in last 2 weeks 
Problems following previous conjunctivitis 
Chronic infective eye condition (eg blepharitis) 
Recent eye surgery (in last month) 
Other (please specify) ______________  _ 
4.  Has your management of  acute infective conjunctivitis changed as a result of 
participating in the trial?  YeslNo 
If Yes, please specify 
5.  Any other comments? (please continue on reverse of  paper if  necessary) 
Thank you! 
Please return this in the free  post envelope with your 'Not entered' book and 
any unused scripts from the delayed prescription box. 
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Conjunctivitis Study Patient Follow-up 
IDno· 
Patient:  Date of Birth: 
Recruiter:  Date of study entry: 
Date:  Completer of this form: 
1)  Has the patient re-attended since the recruitment date with Conjunctivitis or 
suspected conjunctivitis? (see above for recruitment date) 
Yes 
.. 
If yes, please gIVe  dates and  details below and  state whether they received  antibiotics. Please also 
note any referrals to secondary care for eye related symptoms. 
2)  Has the patient re-attended since the recruitment date with other URTls? 
If yes, please give dates and details below and state whether they received antibiotics. 
3)  Did the patient have any consultations for conjunctivitis or suspected  Yes 
conjunctivitis in the year prior to recruitment? 
If yes, please gIVe  dates and  details below and  state whether they received  antibiotics. Please also 
note any referrals to secondary care for eye related symptoms. 
156 
No 
No  , 4)  Did the patient have any consultations for other URTls in the year prior to 
recruitment? 
. . 
If yes, please give dates and details below and state whether they receIVed antibiotics  . 
Please continue below if  you need more space. 
THANK YOU FOR YOUR TIME AND HELP  IN COMPLETING THIS QUESTIONNAIRE 
PLEASE RETURN IN THE FREEPOST ENVELOPE 
Yes  No 
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